Dorothea M Heuberger, Shefali Harankhedkar, Thomas Morgan, Petra Wolint, Maurizio Calcagni, Barry Lai, Christoph J Fahrni, Johanna Buschmann
Copper is an essential trace metal that has been implicated in angiogenesis, the formation of new blood vessels. As tumor growth relies on establishing a functional capillary network for blood supply, copper chelation therapy may hold promise as an anti-cancer strategy by suppressing angiogenesis. To test the anti-angiogenic effect of PSP-2, a recently developed high affinity Cu(I) chelator with low zeptomolar dissociation constant, we utilized the endothelial cancer cell line EAhy926 and assessed changes in cell migration, proliferation, and tube formation in Matrigel...
October 1, 2019: Scientific Reports